| 09/01/2026 7:41 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/24/2026 4:11 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 4:25 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/21/2026 3:35 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/17/2026 9:13 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2026 3:32 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/06/2026 3:36 PM | Oncology Institute (1799191) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/03/2026 8:00 AM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/29/2026 5:46 PM | Johnson Karen Marie (1892819) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/29/2026 5:49 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/29/2026 5:50 PM | Oncology Institute (1799191) Issuer TZOUMAKAS KIMBERLY JO (1766666) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TOIIW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter.
|
| 07/29/2026 5:52 PM | Oncology Institute (1799191) Issuer STOLPER MARK (1281961) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/29/2026 5:53 PM | Oncology Institute (1799191) Issuer Pacala Mark L (1321250) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/29/2026 5:54 PM | McGeorge Anne (1779934) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/29/2026 5:56 PM | Kaushal Mohit (1683021) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/22/2026 8:55 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/16/2026 7:05 PM | Oncology Institute (1799191) Issuer Podnos Yale (1891104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/14/2026 3:33 PM | Oncology Institute (1799191) Subject Podnos Yale (1891104) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/13/2026 10:34 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 3:30 PM | Oncology Institute (1799191) Issuer STOLPER MARK (1281961) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/09/2026 3:30 PM | Oncology Institute (1799191) Issuer TZOUMAKAS KIMBERLY JO (1766666) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/07/2026 4:00 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/24/2026 8:31 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2026 3:30 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/09/2026 6:06 PM | Oncology Institute (1799191) Issuer Podnos Yale (1891104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/08/2026 3:37 PM | Oncology Institute (1799191) Subject Podnos Yale (1891104) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/05/2026 8:38 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 4:37 PM | Oncology Institute (1799191) Issuer Virnich Daniel (1891107) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 4:39 PM | Oncology Institute (1799191) Issuer Podnos Yale (1891104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 4:32 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/21/2026 8:35 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2026 11:25 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 3:16 PM | Oncology Institute (1799191) Filer | Form DEF 14A | |
| 04/30/2026 3:18 PM | Oncology Institute (1799191) Filer | Form DEFA14A | |
| 04/28/2026 3:30 PM | Oncology Institute (1799191) Filer | Form ARS | |
| 04/23/2026 8:24 PM | Langsam Jeffrey (2069752) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/23/2026 8:25 PM | England Kristin (2078090) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 6:27 PM | Kaushal Mohit (1683021) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/14/2026 3:35 PM | Kaushal Mohit (1683021) Reporting Oncology Institute (1799191) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/13/2026 8:03 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 7:57 PM | England Kristin (2078090) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Management just bought 2.8 million shares (Ad) Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 in one quarter.
Institutions own about 83% of shares, including BlackRock's 32 million shares worth $716 million and Vanguard's 48 million shares worth nearly $1.1 billion.
A new multi-year deal with Palantir adds an AI-driven edge to this energy producer's operations. Watch the briefing on this buyback and AI opportunity now |
| 04/01/2026 8:00 PM | Langsam Jeffrey (2069752) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 7:46 PM | Oncology Institute (1799191) Issuer Virnich Daniel (1891107) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 7:47 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 7:51 PM | Oncology Institute (1799191) Issuer Podnos Yale (1891104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/30/2026 8:38 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 8:34 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/25/2026 8:33 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 8:33 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/20/2026 3:34 PM | Oncology Institute (1799191) Issuer TZOUMAKAS KIMBERLY JO (1766666) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/17/2026 6:40 PM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/16/2026 7:30 AM | Chernett Jorey (2042077) Filed by Oncology Institute (1799191) Subject | Form SCHEDULE 13G/A | |
| 03/16/2026 7:32 AM | Chernett Jorey (2042077) Reporting Oncology Institute (1799191) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/13/2026 4:16 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/12/2026 3:56 PM | Oncology Institute (1799191) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/23/2026 3:44 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/15/2026 3:40 PM | Chernett Jorey (2042077) Filed by Oncology Institute (1799191) Subject | Form SCHEDULE 13G | |
| 01/12/2026 3:57 PM | Oncology Institute (1799191) Issuer STOLPER MARK (1281961) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 01/12/2026 7:00 AM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/07/2026 4:02 PM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/06/2026 3:30 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4/A | |
| 01/05/2026 4:04 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 3:30 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:07 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/01/2025 3:45 PM | Ling Gabriel (1945281) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:26 PM | McGeorge Anne (1779934) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:20 PM | Hively Brad (1891124) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:21 PM | Oncology Institute (1799191) Issuer Pacala Mark L (1321250) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:21 PM | Johnson Karen Marie (1892819) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:23 PM | Ling Gabriel (1945281) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/24/2025 4:25 PM | Kaushal Mohit (1683021) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 3:55 PM | Oncology Institute (1799191) Issuer Pacala Mark L (1321250) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 3:01 PM | M33 Growth I L.P. (1718621) Filed by Oncology Institute (1799191) Subject | Form SCHEDULE 13D/A | |
| 11/20/2025 3:02 PM | M33 Growth I GP LLC (1894303) Reporting M33 Growth I L.P. (1718621) Reporting Oncology Institute (1799191) Issuer TOI M, LLC (1892968) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/20/2025 3:02 PM | Ling Gabriel (1945281) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 5:00 PM | Carter Robert Ross (2039341) Reporting Oncology Institute (1799191) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 5:01 PM | Oncology Institute (1799191) Issuer Podnos Yale (1891104) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/19/2025 5:03 PM | Oncology Institute (1799191) Issuer Virnich Daniel (1891107) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/18/2025 3:05 PM | Oncology Institute (1799191) Subject Pacala Mark L (1321250) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/14/2025 5:18 AM | Oncology Institute (1799191) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |